My research interest lies at the intersection of molecular pharmacology and natural product-based drug discovery. I am particularly focused on G protein-coupled receptor (GPCR) pharmacology, exploring their mechanisms and therapeutic potentials. Additionally, I am engaged in in silico-guided drug discovery from natural sources, integrating computational screening with experimental pharmacological validation to identify novel bioactive compounds. This combined approach aims to accelerate the development of effective and safe therapeutics derived from nature for various human diseases including cancers.